Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61
Abstract Background Hyperglycemia in the setting of an acute coronary syndrome (ACS) impacts short term outcomes, but little is known about longer term effects. We therefore designed this study to firstly determine the association between hyperglycemia and short term and longer term outcomes in pati...
Main Authors: | Patric Winzap, Allan Davies, Roland Klingenberg, Slayman Obeid, Marco Roffi, François Mach, Lorenz Räber, Stephan Windecker, Christian Templin, Fabian Nietlispach, David Nanchen, Baris Gencer, Olivier Muller, Christian M. Matter, Arnold von Eckardstein, Thomas F. Lüscher |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-019-0946-6 |
Similar Items
-
Prognosis of cardiovascular and non-cardiovascular multimorbidity after acute coronary syndrome.
by: Silvia Canivell, et al.
Published: (2018-01-01) -
The Roles of CCN1/CYR61 in Pulmonary Diseases
by: Yin Zhu, et al.
Published: (2020-10-01) -
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention.
by: David Carballo, et al.
Published: (2019-01-01) -
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications.
by: Reto Auer, et al.
Published: (2014-01-01) -
Cyr61: a potential therapeutic target for prostate cancer
by: Chang-Ming Lin, et al.
Published: (2014-10-01)